Establishing a mesenchymal stem cell bank from umbilical cord tissue for cell therapy and initial application in the treatment of knee osteoarthritis at Tam Anh general hospital
Author affiliations
DOI:
https://doi.org/10.15625/vjbt-21031Keywords:
Stem cell bank, umbilical cord-derived mesenchymal stem cells, knee osteoarthritisAbstract
Osteoarthritis (OA) is a natural aging process of joints that often occurs as age increases. In knee osteoarthritis, the cartilage that cushions the ends of the thigh bone and shinbone within the knee joint deteriorates, leading to a loss of cushioning and flexibility. This can result in pain, swelling, and stiffness when moving the knee joint. In the treatment of knee osteoarthritis, methods often include symptom management with pain-relieving and anti-inflammatory medications, lifestyle modifications to reduce stress on the knee joint; in some cases, surgery may be considered if nonsurgical interventions are ineffective. Stem cell therapy has emerged as a promising approach for treating knee osteoarthritis. This method has been demonstrated to be safe and effective. Still, one of the most important considerations when using stem cell therapy is quality regulation and safety standards regarding cell culture. This has led to the emergence of stem cell banks, where they are manufactured, preserved and stored. In this study, we utilized stem cells derived from allogeneic umbilical cord tissue. The stem cells were expanded and administered to patients via two injections spaced one month apart, with follow-up lasting an additional six months. The initial treatment results using stem cells for patients with knee osteoarthritis have been very promising. Through assessments of mobility, pain levels (measured by the VAS), and improvement in quality of life (measured by the Lequesne index) over 6 months, the research team has demonstrated the effectiveness of using mesenchymal stem cells (MSCs) from umbilical cord tissue for treating knee osteoarthritis.
Downloads
References
Chatzistamatiou TK, Papassavas AC, Michalopoulos E, Gamaloutsos C, Mallis P, Gontika I, Panagouli E, Koussoulakos SL, Stavropoulos-Giokas C (2014) Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion 54(12): 3108-3120. https://doi.org/10.1111/trf.12743.
de Witte SFH, Lambert EE, Merino A, Strini T, Douben H, O'Flynn L, Elliman SJ, de Klein A, Newsome PN, Baan CC, Hoogduijn MJ (2017) Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion. Cytotherapy 19(7): 798-807. https://doi.org/10.1016/j.jcyt.2017.03.071.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315-317. https://doi.org/10.1080/14653240600855905.
Gupta A, Cady C, Fauser AM, Rodriguez HC, Mistovich RJ, Potty AGR, Maffulli N (2020) Cell-free Stem Cell-Derived Extract Formulation for Regenerative Medicine Applications. Int J Mol Sci 21(24). https://doi.org/10.3390/ijms21249364.
Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Journal of Biomedical Science 12(1): 47-57. https://doi.org/10.1007/s11373-004-8183-7.
Kwon DG, Kim MK, Jeon YS, Nam YC, Park JS, Ryu DJ (2022) State of the Art: The Immunomodulatory Role of MSCs for Osteoarthritis. International journal of molecular sciences 23(3): 1618. https://doi.org/10.3390/ijms23031618.
Loeser RF, Goldring SR, Scanzello CR, Goldring MB (2012) Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64(6): 1697-1707. https://doi.org/10.1002/art.34453.
Makris EA, Gomoll AH, Malizos KN, Hu JC, Athanasiou KA (2015) Repair and tissue engineering techniques for articular cartilage. Nat Rev Rheumatol 11(1): 21-34. https://doi.org/10.1038/nrrheum.2014.157.
Mancuso P, Raman S, Glynn A, Barry F, Murphy JM (2019) Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome. Front Bioeng Biotechnol 7: 9. https://doi.org/10.3389/fbioe.2019.00009.
Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, González PL, Muse E, Khoury M, Figueroa FE, Espinoza F (2019) Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Transl Med 8(3): 215-224. https://doi.org/10.1002/sctm.18-0053.
Meissner-Roloff M, Gaggia L, Vermeulen M, Mazanderani AFH, du Plessis NM, Steel HC, Pepper MS (2018) Strategies for screening cord blood for a public cord blood bank in high HIV prevalence regions. Glob Health Epidemiol Genom 3: e9. https://doi.org/10.1017/gheg.2018.6.
Park YB, Ha CW, Lee CH, Yoon YC, Park YG (2017) Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up. Stem Cells Transl Med 6(2): 613-621. https://doi.org/10.5966/sctm.2016-0157.
Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS, Torshizi Z, Nematollahi-Mahani SN (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim 48(2): 75-83. https://doi.org/10.1007/s11626-011-9480-x.
Schugar RC, Chirieleison SM, Wescoe KE, Schmidt BT, Askew Y, Nance JJ, Evron JM, Peault B, Deasy BM (2009) High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol 2009: 789526. https://doi.org/10.1155/2009/789526.
Shafiqa Naeem Rajput BKN, Anwar Ali, Asmat Salim, Irfan Khan (2024) Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine. World J Stem Cells 16(4). https://doi.org/10.4252/wjsc.v16.i4.410.
Sharaf-Eldin WE, Abu-Shahba N, Mahmoud M, El-Badri N (2016) The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis. Stem Cells International 2016: 1908365. https://doi.org/10.1155/2016/1908365.
Todtenhaupt P, Franken LA, Groene SG, van Hoolwerff M, van der Meeren LE, van Klink JMM, Roest AAW, de Bruin C, Ramos YFM, Haak MC, Lopriore E, Heijmans BT, van Pel M (2023) A robust and standardized method to isolate and expand mesenchymal stromal cells from human umbilical cord. Cytotherapy 25(10): 1057-1068. https://doi.org/10.1016/j.jcyt.2023.07.004.
Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D (2006) Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24(3): 781-792. https://doi.org/10.1634/stemcells.2005-0330.
Xu Y, Huang S, Ma K, Fu X, Han W, Sheng Z (2012) Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity. J Tissue Eng Regen Med 6(8): 645-654. https://doi.org/10.1002/term.468.